We are live on
!
Find out more
HCM
Highbridge Capital Management Portfolio holdings
AUM
$3.09B
1-Year Est. Return
31.19%
This Fund
S&P 500
This Quarter
Est. Return
+4.17%
1 Year Est. Return
+31.19%
3 Year Est. Return
+54.53%
5 Year Est. Return
+78.37%
10 Year Est. Return
+191.39%
AUM
$8.36B
AUM Growth
-$1.11B
(-12%)
Cap. Flow
-$2.9B
Cap. Flow
% of AUM
-34.73%
Top 10 Holdings %
Top 10 Hldgs %
14.55%
Holding
1,631
New
393
Increased
241
Reduced
303
Closed
606
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$83.4M |
| 2 |
Trip.com Group
TCOM
|
+$77.5M |
| 3 |
Expedia Group
EXPE
|
+$77.4M |
| 4 |
FirstEnergy
FE
|
+$56M |
| 5 |
APC
Anadarko Petroleum
APC
|
+$53.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VMW
VMware, Inc
VMW
|
+$89.1M |
| 2 |
Booking.com
BKNG
|
+$62.6M |
| 3 |
Abbott
ABT
|
+$56.3M |
| 4 |
AbbVie
ABBV
|
+$55.7M |
| 5 |
Teradata
TDC
|
+$54.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 10.06% |
| 2 | Technology | 8.16% |
| 3 | Communication Services | 7.9% |
| 4 | Consumer Staples | 7.67% |
| 5 | Healthcare | 7.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
INFN
901
CALL
DELISTED
Infinera Corporation Common Stock
INFN
| $188K | ﹤0.01% |
19,200
-61,400
| -76% | -$610K |
|
902
Alcoa
AA
$11.8B
| $187K | ﹤0.01% |
7,332
-30,020
| -80% | -$666K |
|
|
VIRX
903
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $186K | ﹤0.01% |
+186
| New | +$192K |
|
904
NVIDIA
NVDA
$5.01T
| $181K | ﹤0.01% |
+452,000
| New | +$175K |
|
|
NTRI
905
CALL
DELISTED
NutriSystem, Inc.
NTRI
| $179K | ﹤0.01% |
10,900
-67,600
| -86% | -$1.18M |
|
|
JNY
906
DELISTED
JONES GROUP INC COM STK (PA)
JNY
| $177K | ﹤0.01% |
11,856
-117,291
| -91% | -$1.7M |
|
|
ALJ
907
CALL
DELISTED
Alon USA Energy Inc
ALJ
| $173K | ﹤0.01% |
+10,500
| New | +$133K |
|
|
GCAP
908
DELISTED
Gain Capital Holdings, Inc.
GCAP
| $170K | ﹤0.01% |
+22,573
| New | +$227K |
|
|
XCRA
909
DELISTED
Xcerra Corporation
XCRA
| $169K | ﹤0.01% |
+21,154
| New | +$144K |
|
910
Marvell Technology
MRVL
$174B
| $162K | ﹤0.01% |
11,232
-102,797
| -90% | -$1.32M |
|
|
ZLC
911
CALL
DELISTED
ZALE CORPORATION
ZLC
| $162K | ﹤0.01% |
+10,300
| New | +$156K |
|
912
CALL
American Eagle Outfitters
AEO
$2.99B
| $158K | ﹤0.01% |
+11,000
| New | +$163K |
|
|
CBR
913
DELISTED
CIBER Inc.
CBR
| $158K | ﹤0.01% |
37,989
-179,027
| -82% | -$641K |
|
914
Harte-Hanks
HHS
$14.8M
| $151K | ﹤0.01% |
1,927
-2,798
| -59% | -$228K |
|
915
Cytokinetics
CYTK
$10.4B
| $148K | ﹤0.01% |
22,639
-22,397
| -50% | -$147K |
|
|
TLM
916
DELISTED
TALISMAN ENERGY INC
TLM
| $148K | ﹤0.01% |
+12,700
| New | +$153K |
|
|
MRIN
917
DELISTED
Marin Software
MRIN
| $144K | ﹤0.01% |
+335
| New | +$148K |
|
918
Marchex
MCHX
$84.2M
| $134K | ﹤0.01% |
+15,564
| New | +$135K |
|
|
WG
919
DELISTED
Willbros Group
WG
| $134K | ﹤0.01% |
14,222
+3,096
| +28% | +$28.1K |
|
|
PGTI
920
DELISTED
PGT, Inc.
PGTI
| $132K | ﹤0.01% |
13,122
-31,282
| -70% | -$309K |
|
|
AKS
921
CALL
DELISTED
AK Steel Holding Corp
AKS
| $129K | ﹤0.01% |
+15,700
| New | +$82.9K |
|
922
Lesaka Technologies
LSAK
$401M
| $126K | ﹤0.01% |
14,446
-23,898
| -62% | -$254K |
|
923
Global Ship Lease
GSL
$1.59B
| $123K | ﹤0.01% |
+2,557
| New | +$110K |
|
924
PUT
Calix
CALX
$2.35B
| $121K | ﹤0.01% |
12,500
-4,700
| -27% | -$50.3K |
|
|
LTS
925
DELISTED
Ladenburg Thalmann Financial Services Inc
LTS
| $118K | ﹤0.01% |
+37,528
| New | +$94.5K |
|
Similar funds
DCM
CAM
VBA
MRCP
ECP
TCG
PC
CCI
Highbridge Capital Management's Q4 2013 Portfolio in Review
As of Q4 2013, Highbridge Capital Management held 1,631 positions worth $8.36B, down 12% from $9.47B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Highbridge Capital Management withdrew a net $2.9B in Q4 2013, closing 606 positions and reducing 303 holdings. Its most notable exit was AbbVie, an estimated $55.7M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 10% of assets, up from 9% a quarter earlier, followed by Technology and Communication Services.
Against the trend, Highbridge Capital Management opened a new position in Quest Diagnostics worth $43.3M.
- Highbridge Capital Management's largest Q4 2013 buy was Quest Diagnostics: 809,031 shares worth $43.3M.
- Highbridge Capital Management added most to Apple in Q4 2013, an estimated $83.4M increase.
- Highbridge Capital Management's biggest Q4 2013 reduction was VMware, Inc, cutting an estimated $89.1M.
- Highbridge Capital Management fully exited AbbVie in Q4 2013, selling an estimated $55.7M.
- Highbridge Capital Management's ten largest holdings make up 15% of its $8.36B portfolio in Q4 2013.
- Highbridge Capital Management opened 393 new positions and closed 606 in Q4 2013.
- Highbridge Capital Management's portfolio value fell 12% quarter-over-quarter to $8.36B.
Based on Highbridge Capital Management's 13F filing for Q4 2013, filed 14 Feb 2014.